Evidence map›Paper›PMID 41951625›Full record

ArticleNature communications2026

Bioinspired total synthesis of (+)-pleuromutilin.

Shiyu Hua, Wenshuai Zhong, Lijun Chen, Yanxing Jia

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shiyu Hua *State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Wenshuai Zhong *State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Lijun ChenState Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Yanxing JiaState Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China. yanxingjia@pku.edu.cn.ORCID http://orcid.org/0000-0002-9508-6622

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22331001 and 21925101
6 · The paper itself

Abstract

(+)-Pleuromutilin, a natural antibiotic, possesses an intriguing and complex 5/6/8 tricyclic skeleton with densely packed functional groups. It attracts extensive attention in the field of total synthesis due to its promising antibacterial activity and distinctive structural framework. Here we report the total synthesis of (+)-pleuromutilin inspired by its biosynthetic pathway, which expands the available toolbox, particularly by providing a practical and efficient entry to (+)-12-epi-mutilin. The key steps of the synthesis include a t-BuOK-catalyzed Michael addition to establish the C9 quaternary center, a LiDBB-promoted reductive coupling to construct the five-membered ring, and a bioinspired Zn-mediated Barbier reaction to connect C11 and C12, ultimately enabling the construction of the eight‑membered ring. Starting from (+)-pulegone, we accomplish the total synthesis of (+)-pleuromutilin in 18 steps and (+)-12-epi-mutilin in 16 steps, respectively.

Indexed as

Anti-Bacterial AgentsPleuromutilinsMolecular StructurePolycyclic CompoundsStereoisomerismAnti-Bacterial AgentsPleuromutilinsPolycyclic Compounds

Identifiers

PMID41951625
PMCPMC13237175

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.